What are the possible serious side effects of Aceminid and how to deal with them?

Assimini, as an innovative treatment drug for adults with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML), has opened up a new treatment path for many patients, but the potential serious side effects associated with its use also deserve great attention. For patients and healthcare teams, a thorough understanding and close monitoring of these possible risks is key to ensuring that treatment is safe and effective.

First of all, allergic reactions are an aspect that cannot be ignored in Asiminib treatment. Some patients may experience typical allergic symptoms such as urticaria, itching all over the body, swelling of the face and lips after taking the medicine, and may even be accompanied by discomfort such as dizziness, back pain, and joint pain. If you notice such a reaction, you should seek immediate medical attention for prompt medical intervention.

Hypertension is another important monitoring point in Asiminib treatment. Medications may cause blood pressure to rise abnormally, causing symptoms such as confusion, severe headaches, dizziness, chest pain and shortness of breath. Patients need to monitor their blood pressure regularly and contact their doctor quickly if they experience any of the above discomforts so that the treatment plan can be adjusted.

In addition, aceminib may have a suppressive effect on bone marrow function, resulting in a decrease in blood cell counts. This usually manifests as fever, chills, persistent fatigue, flu-like symptoms, mouth sores, broken skin, and abnormal bleeding. The occurrence of these symptoms may mean that the patient's immune system and hematopoietic function are compromised, and he needs to seek medical attention immediately for professional evaluation.

Pancreatic problems and cardiovascular disease are also potential risks that require special vigilance during treatment with Asiminib. Damage to the pancreas may manifest as sudden, severe pain or discomfort in the stomach, as well as symptoms such as nausea and vomiting. Cardiovascular disease may manifest in the form of shortness of breath, chest pain, palpitations, edema of the lower limbs, dizziness, sudden weight gain, numbness or weakness in parts of the body, decreased or lost vision, slurred speech, and pain in the limbs, back, neck, or jaw.

Faced with these potentially serious side effects, patients should maintain close communication with their doctors and regularly report any physical changes or symptoms of discomfort. Doctors may adjust drug dosages based on the patient's specific conditions, or suspend or even terminate treatment when necessary to ensure patient safety.

In short, although aceminib provides new treatment hope for Ph+ CML patients, the potential risks during its use also require great attention. Patients should, under the guidance of a doctor, fully understand the characteristics of the drug, pay close attention to their own health, and work together to ensure the safety and effectiveness of treatment.

References:

https://www.drugs.com/search.php?searchterm=Scemblix